Intravenous Infusions Plc (GHSE:IIL)

Intravenous Infusions Ratios and Metrics

Market cap in millions GHS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14	14	14	11	14	13
Market Cap Growth	-	-	25.00%	-20.00%	6.02%	-
Enterprise Value	21	24	28	27	25	18
Last Close Price	0.05	0.05	0.05	0.04	0.05	0.04
PE Ratio	-	-	5.40	-	11.97	8.92
PS Ratio	0.71	0.55	0.44	0.54	0.61	0.63
PB Ratio	0.86	0.86	0.79	0.74	0.75	0.72
P/TBV Ratio	0.86	0.87	0.80	0.75	0.75	0.72
P/FCF Ratio	3.08	2.19	5.75	24.26	-	-
P/OCF Ratio	2.16	1.68	3.25	3.82	4.16	-
EV/Sales Ratio	1.08	0.97	0.89	1.31	1.09	0.88
EV/EBITDA Ratio	-	16.52	3.82	-	14.01	7.75
EV/EBIT Ratio	-	29.70	4.29	-	20.14	11.01
EV/FCF Ratio	4.70	3.88	11.72	58.71	-	-
Debt / Equity Ratio	0.52	0.55	0.76	1.09	0.90	0.67
Debt / EBITDA Ratio	-	5.99	1.79	-	9.29	5.08
Debt / FCF Ratio	1.86	1.41	5.50	35.65	-	-
Asset Turnover	0.43	0.55	0.67	0.44	0.54	0.61
Inventory Turnover	2.10	2.17	2.19	1.62	1.76	1.95
Quick Ratio	0.60	0.58	0.81	0.83	1.31	1.59
Current Ratio	0.84	0.83	1.11	1.15	1.86	2.16
Return on Equity (ROE)	-6.96%	-3.87%	15.85%	-21.22%	6.33%	8.14%
Return on Assets (ROA)	-3.18%	1.12%	8.73%	-4.29%	1.83%	3.06%
Return on Capital (ROIC)	-5.37%	1.85%	13.28%	-6.11%	2.38%	3.87%
Return on Capital Employed (ROCE)	-	4.00%	25.40%	-	3.80%	6.30%
Earnings Yield	-8.55%	-4.69%	18.54%	-31.97%	8.36%	11.21%
FCF Yield	32.48%	45.60%	17.39%	4.12%	-28.13%	-34.46%
Dividend Yield	-	-	8.43%	-	-	6.48%
Payout Ratio	-	-	-	-	61.94%	83.22%
Buyback Yield / Dilution	2.87%	-	-	-	-	-7.09%
Total Shareholder Return	-	-	8.43%	-	-	-0.60%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.